Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Concord Biotech IPO.
November 15, 2024 12:26:45 PM
Rekha Rakesh Jhunjhunwala, through multiple discretionary trusts, owned 25,199,240 equity shares, or 24.09 per cent stake in Concord Biotech as of September 30, 2024.
Published by : Business Today on MSNNovember 13, 2024 6:03:00 PM
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their ...
Published by : moneycontrol.comNovember 13, 2024 7:08:00 AM
Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended from time to time we enclose herewith the ...
Published by : Business StandardNovember 6, 2024 7:12:00 PM
Concord Biotech Ltd was originally incorporated as Servomed Pharmaceuticals Private Limited at Ahmedabad, Gujarat as a Private Limited Company dated November 23, 1984, issued by the Registrar of ...
Published by : India InfolineOctober 28, 2024 7:09:00 PM
Concord Healthcare Group Co., Ltd. Class H (HK:2453) has released an update. Concord Healthcare Group Co., Ltd. has addressed a deviation in the use of its IPO proceeds, clarifying that the funds ...
Published by : NasdaqThe IPO Shares of Concord Biotech Limited IPO are proposed to list on Friday, August 18, 2023 at BSE, NSE. The public issue of Concord Biotech IPO was opened on Aug 4, 2023 and closed for subscription on Aug 8, 2023. Concord Biotech IPO Listing Date and Information:
| Listing Date | Friday, August 18, 2023 |
| BSE Script Code | 543960 |
| NSE Symbol | CONCORDBIO |
| Listing In | |
| ISIN | INE338H01029 |
| Issue Price | ₹741 Per Equity Share |
| Face Value | ₹1 Per Equity Share |
The allotment status of Concord Biotech Limited IPO is now available online. The public issue of Concord Biotech IPO was open on Aug 4, 2023 and closed for subscription on Aug 8, 2023. The equity shares of the company to be list at BSE, NSE
.
Concord Biotech Limited is entering in the capital market with an IPO of 20,925,652 Equity Shares of Rs 1 aggregating up to Rs 1,551.00 Crore. The price for the issue has been set at Rs 705 - Rs 741 Per Equity Share.
Incorporated in 1984, Concord Biotech Limited is an India-based R&D-driven biopharma company. The company is ranked among the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in 2022.
The issue opens on Aug 4, 2023 and closes for subscription on Aug 8, 2023. The equity shares of the company to be list at BSE, NSE.
The issue of Concord Biotech Limited opens on Aug 4, 2023 and closes for subscription on Aug 8, 2023. The equity shares of the company to be list at BSE, NSE. The price for the issue has been set at Rs 705 - Rs 741 Per Equity Share.
The Concord Biotech IPO is proposed to open on August 4, 2023. The IPO application ends on August 8, 2023.
Retail investors can apply in the retail or non-institutional investor category from August 4, 2023 to August 8, 2023. The Concord Biotech IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Concord Biotech IPO will open for subscription on August 4, 2023. The public issue will close on August 8, 2023.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
